ATE243027T1 - Sprühgetrocknete mikropartikel als therapeutische träger - Google Patents

Sprühgetrocknete mikropartikel als therapeutische träger

Info

Publication number
ATE243027T1
ATE243027T1 AT97915601T AT97915601T ATE243027T1 AT E243027 T1 ATE243027 T1 AT E243027T1 AT 97915601 T AT97915601 T AT 97915601T AT 97915601 T AT97915601 T AT 97915601T AT E243027 T1 ATE243027 T1 AT E243027T1
Authority
AT
Austria
Prior art keywords
spray
dried microparticles
therapeutic carriers
carriers
therapeutic
Prior art date
Application number
AT97915601T
Other languages
English (en)
Inventor
Andrew Derek Sutton
Jill Elizabeth Ogden
Richard Alan Johnson
Original Assignee
Elan Drug Delivery Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Elan Drug Delivery Ltd filed Critical Elan Drug Delivery Ltd
Application granted granted Critical
Publication of ATE243027T1 publication Critical patent/ATE243027T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes or liposomes coated or grafted with polymers
    • A61K9/1272—Non-conventional liposomes, e.g. PEGylated liposomes or liposomes coated or grafted with polymers comprising non-phosphatidyl surfactants as bilayer-forming substances, e.g. cationic lipids or non-phosphatidyl liposomes coated or grafted with polymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A61K9/1277—Preparation processes; Proliposomes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Dispersion Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Otolaryngology (AREA)
  • Pulmonology (AREA)
  • Biophysics (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AT97915601T 1996-04-03 1997-04-03 Sprühgetrocknete mikropartikel als therapeutische träger ATE243027T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB9607035.4A GB9607035D0 (en) 1996-04-03 1996-04-03 Spray-dried microparticles as therapeutic vehicles
GB9601379 1996-06-07
PCT/GB1997/000953 WO1997036578A1 (en) 1996-04-03 1997-04-03 Spray-dried microparticles as therapeutic vehicles for use in gene therapy

Publications (1)

Publication Number Publication Date
ATE243027T1 true ATE243027T1 (de) 2003-07-15

Family

ID=26308516

Family Applications (1)

Application Number Title Priority Date Filing Date
AT97915601T ATE243027T1 (de) 1996-04-03 1997-04-03 Sprühgetrocknete mikropartikel als therapeutische träger

Country Status (14)

Country Link
EP (1) EP0936902B1 (de)
JP (1) JP2000507568A (de)
AR (1) AR007493A1 (de)
AT (1) ATE243027T1 (de)
AU (1) AU715512B2 (de)
CA (1) CA2250478A1 (de)
DE (1) DE69722952T2 (de)
DK (1) DK0936902T3 (de)
ES (1) ES2201283T3 (de)
GB (1) GB9607035D0 (de)
NO (1) NO984462L (de)
PT (1) PT936902E (de)
WO (1) WO1997036578A1 (de)
ZA (1) ZA972837B (de)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6051256A (en) 1994-03-07 2000-04-18 Inhale Therapeutic Systems Dispersible macromolecule compositions and methods for their preparation and use
EP0965336A1 (de) 1995-11-09 1999-12-22 Microbiological Research Authority Mikroverkapselte DNA zur Gentherapie
US6270795B1 (en) 1995-11-09 2001-08-07 Microbiological Research Authority Method of making microencapsulated DNA for vaccination and gene therapy
US6309623B1 (en) 1997-09-29 2001-10-30 Inhale Therapeutic Systems, Inc. Stabilized preparations for use in metered dose inhalers
US6565885B1 (en) 1997-09-29 2003-05-20 Inhale Therapeutic Systems, Inc. Methods of spray drying pharmaceutical compositions
US20060165606A1 (en) 1997-09-29 2006-07-27 Nektar Therapeutics Pulmonary delivery particles comprising water insoluble or crystalline active agents
US6946117B1 (en) 1997-09-29 2005-09-20 Nektar Therapeutics Stabilized preparations for use in nebulizers
US6433040B1 (en) 1997-09-29 2002-08-13 Inhale Therapeutic Systems, Inc. Stabilized bioactive preparations and methods of use
GB9810236D0 (en) 1998-05-13 1998-07-08 Microbiological Res Authority Improvements relating to encapsulation of bioactive agents
US6406719B1 (en) 1998-05-13 2002-06-18 Microbiological Research Authority Encapsulation of bioactive agents
US7871598B1 (en) 2000-05-10 2011-01-18 Novartis Ag Stable metal ion-lipid powdered pharmaceutical compositions for drug delivery and methods of use
PT1280520E (pt) 2000-05-10 2014-12-16 Novartis Ag Pós à base de fosfolípidos para administração de fármacos
US7575761B2 (en) 2000-06-30 2009-08-18 Novartis Pharma Ag Spray drying process control of drying kinetics
AU2001291721A1 (en) * 2000-08-25 2002-03-04 Merck Patent G.M.B.H Powdered mannitol and mannitol-containing compositions
TWI324518B (en) 2001-12-19 2010-05-11 Nektar Therapeutics Pulmonary delivery of aminoglycosides
US9339459B2 (en) 2003-04-24 2016-05-17 Nektar Therapeutics Particulate materials
EP1765294B1 (de) 2004-05-12 2008-09-24 Baxter International Inc. Nukleinsäure-mikrokügelchen, ihre herstellung und abgabe
US7884085B2 (en) 2004-05-12 2011-02-08 Baxter International Inc. Delivery of AS-oligonucleotide microspheres to induce dendritic cell tolerance for the treatment of autoimmune type 1 diabetes
EP1834651A1 (de) * 2006-03-15 2007-09-19 Universiteit Gent Vakzin-Zusammensetzung und Verfahren zur Vakzin-Herstellung für veterinäre Krankheiten
AU2007281737B2 (en) 2006-08-04 2013-09-19 Baxter Healthcare S.A. Microsphere-based composition for preventing and/or reversing new-onset autoimmune diabetes
CN101686939B (zh) 2007-04-17 2013-03-27 巴克斯特国际公司 用于肺部投送的核酸微粒
DE102009033196A1 (de) * 2009-07-14 2011-01-20 Beiersdorf Ag Kosmetische Zubereitung mit einem Gehalt an dispergierten Mikrosphären
WO2020023533A1 (en) * 2018-07-23 2020-01-30 Translate Bio, Inc. Dry power formulations for messenger rna
CN113438943A (zh) * 2019-01-09 2021-09-24 辛克库姆公司 稳定的无包膜病毒组合物

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9107628D0 (en) * 1991-04-10 1991-05-29 Moonbrook Limited Preparation of diagnostic agents
WO1993025193A1 (fr) * 1992-06-12 1993-12-23 Teijin Limited Preparation pharmaceutique destinee a etre administree par les voies respiratoires
EP0611567B1 (de) * 1992-06-12 2002-08-28 Teijin Limited Ultrafeines pulver zur inhalation und dessen herstellung
WO1994023699A1 (en) * 1993-04-19 1994-10-27 Medisorb Technologies International L.P. Long-acting treatment by slow-release delivery of antisense oligodeoxyribonucleotides from biodegradable microparticles
AU696387B2 (en) * 1994-05-18 1998-09-10 Inhale Therapeutic Systems, Inc. Methods and compositions for the dry powder formulation of interferons
RU2147226C1 (ru) * 1994-09-29 2000-04-10 Квадрант Хэлткэа (Ю Кей) Лимитед Высушенные распылением микрочастицы как терапевтические носители
WO1996027393A1 (en) * 1995-03-07 1996-09-12 University Of Pittsburgh A dry powder formulation for gene therapy
JPH11510142A (ja) * 1995-07-21 1999-09-07 ブラウン・ユニバーシティ・リサーチ・ファンデーション 核酸負荷ポリマー微粒子を使用した遺伝子治療法

Also Published As

Publication number Publication date
DE69722952T2 (de) 2003-12-11
EP0936902A1 (de) 1999-08-25
NO984462D0 (no) 1998-09-25
JP2000507568A (ja) 2000-06-20
EP0936902B1 (de) 2003-06-18
WO1997036578A1 (en) 1997-10-09
AU2302097A (en) 1997-10-22
ZA972837B (en) 1998-04-03
CA2250478A1 (en) 1997-10-09
ES2201283T3 (es) 2004-03-16
GB9607035D0 (en) 1996-06-05
DK0936902T3 (da) 2003-10-06
AU715512B2 (en) 2000-02-03
AR007493A1 (es) 1999-11-10
DE69722952D1 (de) 2003-07-24
PT936902E (pt) 2003-11-28
NO984462L (no) 1998-09-25

Similar Documents

Publication Publication Date Title
DE69722952D1 (de) Sprühgetrocknete mikropartikel als therapeutische träger
FI971332A7 (fi) Suihkukuivatut mikropartikkelit terapeuttisina vehikkeleinä
NO984808L (no) Mikropartikler
DE69713441D1 (de) N-Benzyl-2-phenylindole als östrogene Mittel
NO992806D0 (no) Terapeutiske midler
DE69712436D1 (de) Geschirrspülmaschine
DE69731480D1 (de) Vertikale kriechstromfeste schirme
DE69806141D1 (de) Indazoleamid-verbindungen als serotoninergene mittel
DE59813430D1 (de) Perylenhydrazidimide als Carbonylderivatisierungsreagenzien
DE59707298D1 (de) Desodorierende zubereitungen
FI965079A0 (fi) Anordning vid en spolare
FI963880A0 (fi) Anordning vid en dubbelspolare
DE69722250D1 (de) Spülbecken
FI964699A0 (fi) Maetningsarrangemang vid traeningsredskap foer muskelstyrka
DE60020444D1 (de) Melanoma Therapie
KR970060530U (ko) 유아용 침대
KR970050823U (ko) 유아용 침대
IS4347A (is) Flutningsstykki fyrir innyfli úr dýrum
FI962662A0 (fi) Anordning vid en kabelspolare
FI964814A0 (fi) Anordning vid en fiberlinje
FI961009A0 (fi) Vipparmstillaempning vid instaellningsmekanism foer ventiler
FI961328A0 (fi) Steganordning vid fordon
FI960338A0 (fi) Anordning vid underjordiska roersystem
FI964966A0 (fi) Anordning vid en anestesibaetskebehaollare
NO974628L (no) Beger

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 0936902

Country of ref document: EP

EEFA Change of the company name
REN Ceased due to non-payment of the annual fee